pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute for clinical programs — 83 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
George Institute for projects
83 ClinicalTrials.gov programs sponsored by George Institute for.
George Institute for has 83 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
-
The George Institute
Acute lower Respiratory Tract Infection or acute rhinosinusitis
1 trial -
2024/3873 CABOLD
The George Institute
Renal carcinoma
1 trial -
AB.OH.2025
The George Institute
Infectious diseases
1 trial -
ACETYLSALICYLIC ACID
The George Institute
Obstetrics – Preeclampsia
1 trial -
ADIPGEN
The George Institute
Knee Osteoarthritis
1 trial -
ALLERDOG
The George Institute
Allergic rhinitis due to dog allergy
1 trial -
AMOXICILINA NORMON 1000 mg Comprimidos EFG
The George Institute
Infective endocarditis
1 trial -
ANGELO
The George Institute
Obesity
1 trial -
Alirocumab, Placebo product for REGN727
The George Institute
Cardiac allograft vaculopathy in recent heart transplant recipients
1 trial -
Amiodarone hydrochloride 200 mg tablets
The George Institute
Persistent atrial fibrillation
1 trial -
Avian_inf_vacc_THL20
The George Institute
Avian influenza and seasonal influenza
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID... for COVID-19 infection
The George Institute
COVID-19 infection
1 trial -
BUDESONIDE
The George Institute
Chronic obstructive pulmonary disease (COPD)
1 trial -
CARDIOPLEGIA SOLUTIONS
The George Institute
Cardiovascular pathology
1 trial -
CARFLECT IV
The George Institute
Idiopathic ventricular arrhythmias
1 trial -
CEFOSPROST
The George Institute
Acute bacterial prostatitis
1 trial -
CITISILONG
The George Institute
Active smokers
1 trial -
CLEAN+
The George Institute
colorectal cancer early detection
1 trial -
CoLeBu
The George Institute
Hip fracture
1 trial -
Cyclogest 400 mg óvulos
The George Institute
Infertility
1 trial -
DARBEPOETIN ALFA
The George Institute
hepatic trasplant
1 trial -
DOBUTAMINE , LEVOSIMENDAN
The George Institute
Heart failure patients with depressed left ventricular ejection fraction
1 trial -
ENDORET-PRGF
The George Institute
pterygium
1 trial -
ENRICH-AF
The George Institute
High risk atrial fibrillation patients with previous intracranial hemorrhage
1 trial -
EPHIC-DIA2
The George Institute
Type 2 Diabetes Mellitus
1 trial -
Eliquis film-coated tablets for Left ventricular thrombosis., A…
The George Institute
Left ventricular thrombosis., Acute mycocardial infarction (AMI)
1 trial -
FOSFOMYCIN
The George Institute
Uncomplicated urinary tract infection (uUTI)
1 trial -
Ferinject 50 mg/ml dispersión inyectable y para perfusión
The George Institute
Anemia in patients with chronic ischemia of the lower limb ischemia
1 trial -
Ferinject 50 mg/ml dispersión inyectable y para perfusión
The George Institute
Acute coronary syndrome
1 trial -
GadoCrohn
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Gardasil 9 suspension for Evaluation of the reduction of…
The George Institute
Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV
1 trial -
HCB.2021.1309
The George Institute
Coronary artery chronic total occlusion
1 trial -
HEBRO-001
The George Institute
Hypertension
1 trial -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.
The George Institute
Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).
1 trial -
ICI22/00054
The George Institute
patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment
1 trial -
IIBSP-FAS-2020-120
The George Institute
Complicated acute appendicitis
1 trial -
IIBSP-HOP-2021-01
The George Institute
Acute Ischemic Stroke
1 trial -
IIBSP-OXI-2022-124
The George Institute
Borderline Personality Disorder.
1 trial -
IJG-PREMI-2024
The George Institute
Migraine
1 trial -
INDOCYANINE GREEN
The George Institute
Patients with liver tumors that will undergo minimally invasive liver surgery
1 trial -
INFLUENZA for Influenza, Immunity against inf…
The George Institute
Influenza, Immunity against influenza
1 trial -
Iomeron 400 mgI/ml solution for injection
The George Institute
Thoracic neoplasm
1 trial -
KTI2023
The George Institute
Graft pyelonephritis in kidney transplant recipients
1 trial -
LINEZOLID, LINEZOLID
The George Institute
Sepsis
1 trial -
LIVTENCITY 200 mg film-coated tablets.
The George Institute
Transplant patients with high recurrent Epstein-Barr infection
1 trial -
LUTI Study
The George Institute
Infertility
1 trial -
MAMBO-II
The George Institute
Migraine
1 trial
Frequently asked questions
How many clinical projects does George Institute for have?
83 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.